Igm Biosciences logo

Igm Biosciences Share Price Today

(NASDAQ: IGMS)

Igm Biosciences share price is $1.35 & ₹117.41 as on 6 Mar 2025, 2.30 'hrs' IST

$1.35

0.02

(1.5%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Igm Biosciences share price in Dollar and Rupees. Guide to invest in Igm Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Igm Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Igm Biosciences share price movements

  • Today's Low: $1.30
    Today's High: $1.37

    Day's Volatility :5.11%

  • 52 Weeks Low: $1.25
    52 Weeks High: $22.50

    52 Weeks Volatility :94.44%

Igm Biosciences (IGMS) Returns

PeriodIgm Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-85.94%
2.1%
0.0%
6 Months
-87.02%
-4.1%
0.0%
1 Year
-89.12%
2.2%
0.0%
3 Years
-91.52%
11.8%
-11.6%

Igm Biosciences (IGMS) Key Statistics

in dollars & INR

Previous Close
$1.33
Open
$1.33
Today's High
$1.37
Today's Low
$1.3
Market Capitalization
$75.8M
Today's Volume
$64.6K
52 Week High
$22.5
52 Week Low
$1.25
Revenue TTM
$2.9M
EBITDA
$-224.0M
Earnings Per Share (EPS)
$-3.57
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-132.11%

How to invest in Igm Biosciences Stock (IGMS) from India?

It is very easy for Indian residents to invest directly in Igm Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Igm Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Igm Biosciences or IGMS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Igm Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Igm Biosciences shares which would translate to 0.644 fractional shares of Igm Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Igm Biosciences, in just a few clicks!

Returns in Igm Biosciences (IGMS) for Indian investors in Rupees

The Igm Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Igm Biosciences investment value today

Current value as on today

₹16,010

Returns

₹83,990

(-83.99%)

Returns from Igm Biosciences Stock

₹88,953 (-88.95%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Igm Biosciences (IGMS)

-80%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Igm Biosciences Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Igm Biosciences

  • Baker Bros Advisors LP

    6.89%

  • T. Rowe Price Associates, Inc.

    6.00%

  • Siren, L.L.C.

    5.60%

  • Redmile Group, LLC

    4.96%

  • BlackRock Inc

    1.77%

  • Goldman Sachs Group Inc

    1.65%

Analyst Recommendation on Igm Biosciences

Buy

    66%Buy

    33%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Igm Biosciences(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
9
Hold
5
5
6
Sell
0
0
0

Analyst Forecast on Igm Biosciences Stock (IGMS)

What analysts predicted

Upside of 116.05%

Target:

$2.92

Current:

$1.35

Insights on Igm Biosciences Stock (Ticker Symbol: IGMS)

  • Price Movement

    In the last 3 months, IGMS stock has moved down by -85.9%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.25M → 516.0K (in $), with an average decrease of 58.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -47.90M → -61.43M (in $), with an average decrease of 28.2% per quarter
  • IGMS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 151.3%
  • IGMS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 139.2%
  • Price to Sales

    ForIGMS every $1 of sales, investors are willing to pay $27.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Igm Biosciences Technicals Summary

Sell

Neutral

Buy

Igm Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Igm Biosciences (IGMS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Igm Biosciences Inc logo
-6.99%
-87.02%
-89.12%
-91.52%
-97.43%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Igm Biosciences Inc logo
NA
NA
NA
-3.4
-1.32
-0.37
NA
1.33
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Igm Biosciences Inc logo
Buy
$75.8M
-97.43%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Igm Biosciences

IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops Aplitabart, a Death Receptor 5 Agonist IgM antibody for the treatment of colorectal cancer; imvotamab, a CD20 x CD3 bispecific IgM antibody to treat myositis, as well as for the treatment of systemic lupus erythematosus and rheumatoid arthritis that is Phase Ib clinical trial; and IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of autoimmune diseases. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Organization
Igm Biosciences
Employees
198
CEO
Ms. Mary Beth Harler M.D.
Industry
Health Technology

Management People of Igm Biosciences

NameTitle
Ms. Mary Beth Harler M.D.
CEO & Director
Mr. Misbah Tahir CPA
Chief Financial Officer
Mr. TS Harigopal
Senior Vice President of Group Operations
Mr. Steven Weber
Senior VP, Corporate Controller & Principal Accounting Officer
Mr. Paul C. Graffagnino J.D.
Senior Vice President of Legal Affairs
Ms. Suzette Tauber
Chief Human Resources Officer
Dr. Angus M. Sinclair Ph.D.
Executive Vice President of Research
Dr. Lisa L. Decker Ph.D.
Chief Business Officer
Dr. Marvin S. Peterson Ph.D.
Executive Vice President of Process Development & Manufacturing
Dr. Elizabeth Haanes J.D., Ph.D.
Senior Vice President of Intellectual Property

Important FAQs about investing in IGMS Stock from India :

What is Igm Biosciences share price today?

Igm Biosciences share price today stands at $1.35, Open: $1.33 ; Previous Close: $1.33 ; High: $1.37 ; Low: $1.30 ; 52 Week High: $22.50 ; 52 Week Low: $1.25.

The stock opens at $1.33, after a previous close of $1.33. The stock reached a daily high of $1.37 and a low of $1.30, with a 52-week high of $22.50 and a 52-week low of $1.25.

Can Indians buy Igm Biosciences shares?

Yes, Indians can invest in the Igm Biosciences (IGMS) from India.

With INDmoney, you can buy Igm Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Igm Biosciences at zero transaction cost.

How can I buy Igm Biosciences shares from India?

It is very easy to buy Igm Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Igm Biosciences (IGMS) be purchased?

Yes, you can buy fractional shares of Igm Biosciences with INDmoney app.

What are the documents required to start investing in Igm Biosciences stocks?

To start investing in Igm Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Igm Biosciences Stock (IGMS)?

Today’s highest price of Igm Biosciences (IGMS) is $1.37.

Today’s lowest price of Igm Biosciences (IGMS) is $1.30.

What is today's market capitalisation of Igm Biosciences?

Today's market capitalisation of Igm Biosciences IGMS is 75.8M

What is the 52 Week High and Low Range of Igm Biosciences Stock (IGMS)?

  • 52 Week High

    $22.50

  • 52 Week Low

    $1.25

What are the historical returns of Igm Biosciences (IGMS)?

  • 1 Month Returns

    -6.99%

  • 3 Months Returns

    -87.02%

  • 1 Year Returns

    -89.12%

  • 5 Years Returns

    -97.43%

Who is the Chief Executive Officer (CEO) of Igm Biosciences ?

Ms. Mary Beth Harler M.D. is the current Chief Executive Officer (CEO) of Igm Biosciences.